 | • レポートコード：MRC2-11QY13669 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアルツハイマー病のグローバル市場について調査・分析したレポートです。種類別（ドネペジル、メマンチン、リバスチグミン）市場規模、用途別（初期～中度段階、中度～重度段階）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アルツハイマー病の競争状況、市場シェア ・世界のアルツハイマー病市場：種類別市場規模 2015年-2020年（ドネペジル、メマンチン、リバスチグミン） ・世界のアルツハイマー病市場：種類別市場規模予測 2021年-2026年（ドネペジル、メマンチン、リバスチグミン） ・世界のアルツハイマー病市場：用途別市場規模 2015年-2020年（初期～中度段階、中度～重度段階） ・世界のアルツハイマー病市場：用途別市場規模予測 2021年-2026年（初期～中度段階、中度～重度段階） ・北米のアルツハイマー病市場分析：米国、カナダ ・ヨーロッパのアルツハイマー病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアルツハイマー病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアルツハイマー病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアルツハイマー病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Eisai、Novartis、Daiichi Sankyo、Merz Pharma、Pfizer、Johnson & Johnson、Lundbeck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Alzheimer’s Disease Market
The global Alzheimer’s Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alzheimer’s Disease Scope and Market Size
Alzheimer’s Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer’s Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Market segment by Type, the product can be split into
Donepezil
Memantine
Rivastigmine
Market segment by Application, split into
Early to Moderate Stages
Moderate to Severe Stages
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Alzheimer’s Disease Revenue
1.4 Market by Type
1.4.1 Global Alzheimer’s Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Donepezil
1.4.3 Memantine
1.4.4 Rivastigmine
1.5 Market by Application
1.5.1 Global Alzheimer’s Disease Market Share by Application: 2020 VS 2026
1.5.2 Early to Moderate Stages
1.5.3 Moderate to Severe Stages
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Market Perspective (2015-2026)
2.2 Global Alzheimer’s Disease Growth Trends by Regions
2.2.1 Alzheimer’s Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Alzheimer’s Disease Historic Market Share by Regions (2015-2020)
2.2.3 Alzheimer’s Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Alzheimer’s Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Alzheimer’s Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Players by Market Size
3.1.1 Global Top Alzheimer’s Disease Players by Revenue (2015-2020)
3.1.2 Global Alzheimer’s Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Alzheimer’s Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Alzheimer’s Disease Market Concentration Ratio
3.2.1 Global Alzheimer’s Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Revenue in 2019
3.3 Alzheimer’s Disease Key Players Head office and Area Served
3.4 Key Players Alzheimer’s Disease Product Solution and Service
3.5 Date of Enter into Alzheimer’s Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alzheimer’s Disease Historic Market Size by Type (2015-2020)
4.2 Global Alzheimer’s Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Alzheimer’s Disease Market Size by Application (2015-2020)
5.2 Global Alzheimer’s Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Alzheimer’s Disease Market Size (2015-2020)
6.2 Alzheimer’s Disease Key Players in North America (2019-2020)
6.3 North America Alzheimer’s Disease Market Size by Type (2015-2020)
6.4 North America Alzheimer’s Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Alzheimer’s Disease Market Size (2015-2020)
7.2 Alzheimer’s Disease Key Players in Europe (2019-2020)
7.3 Europe Alzheimer’s Disease Market Size by Type (2015-2020)
7.4 Europe Alzheimer’s Disease Market Size by Application (2015-2020)
8 China
8.1 China Alzheimer’s Disease Market Size (2015-2020)
8.2 Alzheimer’s Disease Key Players in China (2019-2020)
8.3 China Alzheimer’s Disease Market Size by Type (2015-2020)
8.4 China Alzheimer’s Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Alzheimer’s Disease Market Size (2015-2020)
9.2 Alzheimer’s Disease Key Players in Japan (2019-2020)
9.3 Japan Alzheimer’s Disease Market Size by Type (2015-2020)
9.4 Japan Alzheimer’s Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Alzheimer’s Disease Market Size (2015-2020)
10.2 Alzheimer’s Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Alzheimer’s Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Alzheimer’s Disease Market Size by Application (2015-2020)
11 India
11.1 India Alzheimer’s Disease Market Size (2015-2020)
11.2 Alzheimer’s Disease Key Players in India (2019-2020)
11.3 India Alzheimer’s Disease Market Size by Type (2015-2020)
11.4 India Alzheimer’s Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Alzheimer’s Disease Market Size (2015-2020)
12.2 Alzheimer’s Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Alzheimer’s Disease Market Size by Type (2015-2020)
12.4 Central & South America Alzheimer’s Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Alzheimer’s Disease Introduction
13.1.4 Allergan Revenue in Alzheimer’s Disease Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Eisai
13.2.1 Eisai Company Details
13.2.2 Eisai Business Overview
13.2.3 Eisai Alzheimer’s Disease Introduction
13.2.4 Eisai Revenue in Alzheimer’s Disease Business (2015-2020)
13.2.5 Eisai Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Alzheimer’s Disease Introduction
13.3.4 Novartis Revenue in Alzheimer’s Disease Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Details
13.4.2 Daiichi Sankyo Business Overview
13.4.3 Daiichi Sankyo Alzheimer’s Disease Introduction
13.4.4 Daiichi Sankyo Revenue in Alzheimer’s Disease Business (2015-2020)
13.4.5 Daiichi Sankyo Recent Development
13.5 Merz Pharma
13.5.1 Merz Pharma Company Details
13.5.2 Merz Pharma Business Overview
13.5.3 Merz Pharma Alzheimer’s Disease Introduction
13.5.4 Merz Pharma Revenue in Alzheimer’s Disease Business (2015-2020)
13.5.5 Merz Pharma Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Alzheimer’s Disease Introduction
13.6.4 Pfizer Revenue in Alzheimer’s Disease Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Alzheimer’s Disease Introduction
13.7.4 Johnson & Johnson Revenue in Alzheimer’s Disease Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Lundbeck
13.8.1 Lundbeck Company Details
13.8.2 Lundbeck Business Overview
13.8.3 Lundbeck Alzheimer’s Disease Introduction
13.8.4 Lundbeck Revenue in Alzheimer’s Disease Business (2015-2020)
13.8.5 Lundbeck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Alzheimer's Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Alzheimer's Disease Revenue
Table 3. Ranking of Global Top Alzheimer's Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Alzheimer's Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Donepezil
Table 6. Key Players of Memantine
Table 7. Key Players of Rivastigmine
Table 8. Global Alzheimer's Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Alzheimer's Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Alzheimer's Disease Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Alzheimer's Disease Market Share by Regions (2015-2020)
Table 12. Global Alzheimer's Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Alzheimer's Disease Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Alzheimer's Disease Market Growth Strategy
Table 18. Main Points Interviewed from Key Alzheimer's Disease Players
Table 19. Global Alzheimer's Disease Revenue by Players (2015-2020) (Million US$)
Table 20. Global Alzheimer's Disease Market Share by Players (2015-2020)
Table 21. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease as of 2019)
Table 22. Global Alzheimer's Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Alzheimer's Disease Product Solution and Service
Table 25. Date of Enter into Alzheimer's Disease Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 28. Global Alzheimer's Disease Market Size Share by Type (2015-2020)
Table 29. Global Alzheimer's Disease Revenue Market Share by Type (2021-2026)
Table 30. Global Alzheimer's Disease Market Size Share by Application (2015-2020)
Table 31. Global Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 32. Global Alzheimer's Disease Market Size Share by Application (2021-2026)
Table 33. North America Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Alzheimer's Disease Market Share (2019-2020)
Table 35. North America Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 36. North America Alzheimer's Disease Market Share by Type (2015-2020)
Table 37. North America Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 38. North America Alzheimer's Disease Market Share by Application (2015-2020)
Table 39. Europe Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Alzheimer's Disease Market Share (2019-2020)
Table 41. Europe Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Alzheimer's Disease Market Share by Type (2015-2020)
Table 43. Europe Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Alzheimer's Disease Market Share by Application (2015-2020)
Table 45. China Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 46. China Key Players Alzheimer's Disease Market Share (2019-2020)
Table 47. China Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 48. China Alzheimer's Disease Market Share by Type (2015-2020)
Table 49. China Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 50. China Alzheimer's Disease Market Share by Application (2015-2020)
Table 51. Japan Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Alzheimer's Disease Market Share (2019-2020)
Table 53. Japan Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Alzheimer's Disease Market Share by Type (2015-2020)
Table 55. Japan Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Alzheimer's Disease Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Alzheimer's Disease Market Share (2019-2020)
Table 59. Southeast Asia Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Alzheimer's Disease Market Share by Type (2015-2020)
Table 61. Southeast Asia Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Alzheimer's Disease Market Share by Application (2015-2020)
Table 63. India Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 64. India Key Players Alzheimer's Disease Market Share (2019-2020)
Table 65. India Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 66. India Alzheimer's Disease Market Share by Type (2015-2020)
Table 67. India Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 68. India Alzheimer's Disease Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Alzheimer's Disease Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Alzheimer's Disease Market Share (2019-2020)
Table 71. Central & South America Alzheimer's Disease Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Alzheimer's Disease Market Share by Type (2015-2020)
Table 73. Central & South America Alzheimer's Disease Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Alzheimer's Disease Market Share by Application (2015-2020)
Table 75. Allergan Company Details
Table 76. Allergan Business Overview
Table 77. Allergan Product
Table 78. Allergan Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 79. Allergan Recent Development
Table 80. Eisai Company Details
Table 81. Eisai Business Overview
Table 82. Eisai Product
Table 83. Eisai Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 84. Eisai Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Daiichi Sankyo Company Details
Table 91. Daiichi Sankyo Business Overview
Table 92. Daiichi Sankyo Product
Table 93. Daiichi Sankyo Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 94. Daiichi Sankyo Recent Development
Table 95. Merz Pharma Company Details
Table 96. Merz Pharma Business Overview
Table 97. Merz Pharma Product
Table 98. Merz Pharma Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 99. Merz Pharma Recent Development
Table 100. Pfizer Company Details
Table 101. Pfizer Business Overview
Table 102. Pfizer Product
Table 103. Pfizer Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 104. Pfizer Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Lundbeck Business Overview
Table 111. Lundbeck Product
Table 112. Lundbeck Company Details
Table 113. Lundbeck Revenue in Alzheimer's Disease Business (2015-2020) (Million US$)
Table 114. Lundbeck Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer's Disease Market Share by Type: 2020 VS 2026
Figure 2. Donepezil Features
Figure 3. Memantine Features
Figure 4. Rivastigmine Features
Figure 5. Global Alzheimer's Disease Market Share by Application: 2020 VS 2026
Figure 6. Early to Moderate Stages Case Studies
Figure 7. Moderate to Severe Stages Case Studies
Figure 8. Alzheimer's Disease Report Years Considered
Figure 9. Global Alzheimer's Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Alzheimer's Disease Market Share by Regions: 2020 VS 2026
Figure 11. Global Alzheimer's Disease Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Alzheimer's Disease Market Share by Players in 2019
Figure 14. Global Top Alzheimer's Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alzheimer's Disease as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Alzheimer's Disease Revenue in 2019
Figure 16. North America Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Alzheimer's Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
アルツハイマー病治療法の世界市場（～2026年） Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia. Europe is estimated to grow at a rapid pace owing to the high prevalence of AD coupled with e…- アルツハイマーの世界市場（～2026年） Alzheimer’s is a neurodegenerative progressive disease. Alzheimer's disease is a type of dementia whichludes a broad group of brain diseasessuch as problems with memorythinkingand behavior for the long term. It is a type of dementia and near about 60-70% of Alzheimer's disease is the cause of dement…
- アルツハイマー病治療の世界市場（～2026年） Market Analysis and Insights: Global Alzheimer’s Therapeutic Market The global Alzheimer’s Therapeutic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alzheimer’s Therapeutic Scope and Market Size Alzheimer’s Therapeut…
- 脳疾患の世界市場（～2026年） Brain diseases a part of central nervous system diseases, is a condition where the brain structure or functions alter. The brain diseases include conditions or disabilities that affect the brain. Mostly brain disorders occur due to traumatic injury, genetic or other diseases, while a small number of…
- アルジマー病・認知症の世界市場（～2026年） The global dementia associated with Alzheimer’s disease market has been segmented based on drug class and distribution channel. In terms of drug class, the global market has been classified into cholinergic/ cholinesterase (ChE) inhibitor, memantine, and combined drug (memantine & donepezil) and oth…